Scholarly Index
Christopher S. Ambrose
AstraZeneca (United States); 6,068 total citations; 269 total publications; best world rank #54
AstraZeneca (United States)
6,068Total citations
269Total publications
41H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Respiratory viral infections research | Lifetime | 521 | US 257 | 98.14 |
| Influenza Virus Research Studies | Lifetime | 458 | US 208 | 97.96 |
| Pneumonia and Respiratory Infections | Lifetime | 998 | US 374 | 96.98 |
| Asthma and respiratory diseases | 2021-2025 | 165 | US 42 | 98.47 |
| Respiratory and Cough-Related Research | 2021-2025 | 54 | US 11 | 97.94 |
| Inhalation and Respiratory Drug Delivery | 2021-2025 | 110 | US 26 | 93.98 |
| Allergic Rhinitis and Sensitization | 2021-2025 | 361 | US 94 | 94.19 |
| Chronic Obstructive Pulmonary Disease (COPD) Research | 2021-2025 | 634 | US 133 | 92.82 |
| Eosinophilic Esophagitis | 2021-2025 | 605 | US 204 | 88.18 |
| Pharmaceutical studies and practices | 2021-2025 | 595 | US 185 | 80.56 |